AzTrials
AzTrials

Nursing StudentsNCT07349862

Flipped Learning in Nursing Education

A study testing ChatGPT-Based Flıpped Learning Model and Traditional Flıpped Learning Model in people with Nursing Students and Education, run by Namik Kemal University at 1 site in Turkey (Türkiye).

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to examine the effects of cancer screening training, conducted using a ChatGPT-based flipped learning model, on knowledge, learning motivation, and class participation. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
What is being tested?
ChatGPT-Based Flıpped Learning Model and Traditional Flıpped Learning Model
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Dec 2025to 15 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Students who have taken courses in fundamentals of nursing, internal medicine nursing, physiology, pathology, and computer science, but have not taken a course in oncology nursing,
  • Third-year students,
  • Those who have voluntarily agreed to participate in the study.

Who cannot join

  • Students who were not third-year students,
  • Those who had not taken one of the following courses: fundamentals of nursing, internal medicine nursing, physiology, pathology, computer science, oncology nursing,
  • Those who did not volunteer to participate in the research were excluded from the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Tekirdag Namık Kemal University

    Tekirdağ, Suleymanpasa, 59030

Other trials in Turkey (Türkiye)

About this study

Official title: THE IMPACT OF CANCER SCREENING TRAINING, CONDUCTED USING A CHATGPT-SUPPORTED FLIPPED LEARNING MODEL, ON NURSING STUDENTS' ACADEMIC KNOWLEDGE, LEARNING MOTIVATION, AND CLASSROOM ENGAGEMENT

This study aims to examine the effects of cancer screening training, conducted using a ChatGPT-based flipped learning model, on knowledge, learning motivation, and class participation.

Read the detailed description

Methods: A randomized controlled trial was conducted with 46 intervention and 46 control groups. In the study, a training program based on traditional flipped learning and a ChatGPT-based flipped learning model for cancer screenings is applied. Data will be collected using the Knowledge Form, Cancer Screening Knowledge Scale, Higher Education Learning Motivation Scale, and Class Participation Scale.

Being tested
ChatGPT-Based Flıpped Learning Model, Traditional Flıpped Learning Model
Keywords
learning motivation, classroom engagement, flipped learning, ChatGPT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ChatGPT-Based Flıpped Learning ModelOther

    Training group based on ChatGPT-based flipped learning model

  • Traditional Flıpped Learning ModelOther

    Training group based on traditional flipped learning model

Study groups in NCT07349862
Study groupRoleWhat they receive
Intervention group- ChatGPT Flipped LearningExperimentalChatGPT-Based Flıpped Learnıng Model
Receives: Other: ChatGPT-Based Flıpped Learning Model
Control Group- Traditioanl Flipped LearningPlacebo comparatorTraditional Flıpped Learnıng Model
Receives: Other: Traditional Flıpped Learning Model

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cancer Screening Knowledge Scale

    This scale consists of 25 items and 3 sub-dimensions. The sub-dimensions are not specifically named. The first sub-dimension contains 10 items (items 8, 17-23, 25, 28), the second sub-dimension contains 9 items (items 4, 5, 7, 10, 12, 13, 15, 16, 27), and the third sub-dimension contains 6 items (items 1-3, 9, 11, 24). The scale is a three-point rating scale. The scale is answered on a scale of 1 to 3, with "1: True, 2: False, 3: I don't know". When calculating the scale score, "True" answers are worth 1 point, and "False" and "I don't know" answers are worth 0 points. The lowest possible score on the scale is 0, and the highest is 25. When calculating the scale score, the three items with negative connotations (Items 2, 11, 24) should be reverse-coded. The order of the items on the scale is not important; researchers may use a mixed order. There is no cutoff point for the scale score.

    Measured: 4 weeks

Secondary outcomes (1)
  1. Learning Motivation Scale in Higher Education

    The scale consisting of 23 items on a 3-point Likert scale, participants are given scores of Disagree (1), Don't Know (2), and Agree (3) for each question in the Learning Motivation Scale in Higher Education. The lowest possible score is 23 and the highest is 69. In the reliability studies of the scale, the Cronbach alpha coefficient of the learning objectives sub-dimension was calculated as 0.83, the avoidance objectives sub-dimension as 0.87, and the approach objectives sub-dimension as 0.82.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2026
  2. Study start1 Dec 2025
  3. Primary completion30 Jan 2026 (estimated)
  4. Study completion15 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized controlled trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07349862
Sponsor's protocol ID
DERDEN-4
Status last verified
Jan 2026
First submitted
22 Dec 2025
Last updated
20 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: I can share it with researchers who request it for reasonable reasons.

Questions about this trial

What is this clinical trial studying?

A study testing ChatGPT-Based Flıpped Learning Model and Traditional Flıpped Learning Model in people with Nursing Students and Education, run by Namik Kemal University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cancer Screening Knowledge Scale (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in